Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 4 boards, counting each seat separately. Longest: Vera Therapeutics Inc., 3 years.
Vera Therapeutics Inc.
Director
Jazz Pharmaceuticals plc
Director
Zenas BioPharma Inc.
Director
BioAge Labs Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 27, 2024 | BioAge Labs Inc. | Derivative conversion | +1,310,589 | — | — |
| Sep 27, 2024 | BioAge Labs Inc. | Open-market purchase | +400,000 | $18.00 | $7,200,000 |
| Sep 16, 2024 | Zenas BioPharma Inc. | Derivative conversion | +723,812 | — | — |
| Sep 16, 2024 | Zenas BioPharma Inc. | Derivative conversion | +1,003,592 | — | — |
| Sep 16, 2024 | Zenas BioPharma Inc. | Derivative conversion | +334,530 | — | — |
| Sep 16, 2024 | Zenas BioPharma Inc. | Open-market purchase | +440,000 | $17.00 | $7,480,000 |
| Aug 2, 2024 | Jazz Pharmaceuticals plc | Grant or award | +3,731 | — | — |
| Aug 14, 2023 | Jazz Pharmaceuticals plc | Open-market sale | −1,241 | $138.16 | $171,457 |
| Aug 11, 2023 | Jazz Pharmaceuticals plc | Grant or award | +3,075 | — | — |
| Feb 6, 2023 | Vera Therapeutics Inc. | Open-market purchase | +1,714,285 | $7.00 | $11,999,995 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.